Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine for ADHD and Marijuana Dependence
NCT00360269Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Nov 2005
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atomoxetine in cannabis use disorder (CUD), attention deficit hyperactivity disorder (ADHD), sponsored by Medical University of South Carolina. Started Nov 2005; status: completed.
02
Drugs
atomoxetine
03
Conditions
cannabis use disorder (CUD)attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00360269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00360269.